Yonsei University Severance Hospital Gastroenterology Ahn Sang-hun

Ahn Sang-hun

Yonsei University Severance Hospital|Gastroenterology

Seoul Seodaemun-gu

Last updated

Provides care specializing in hepatitis B and C and fatty liver disease, supported by clinical expertise from multicenter research and numerous publications.

Medical opinions · Patient reviews0

No reviews yet.

If you've been treated by Ahn Sang-hun, be the first to leave a review.

Planning to see Ahn Sang-hun?

Save this doctor and find them again anytime on My page.

Hospital information

Address
50-1 Yonsei-ro, Seodaemun-gu, Seoul
University
연세대학교 의과대학
Appointments
1599-1004Book by phone (1599-1004)
1588-7757건강검진 예약하기 (1588-7757)
All doctors at Yonsei University Severance Hospital

Education and career

Education

  • Bachelor of Medicine (1995), Master of Medicine (1998), and Doctor of Medicine (2003), Yonsei University College of Medicine
  • Completed the mini-MBA program at Yonsei University Graduate School of Business
  • [Overseas Training]
  • Completed postdoctoral training at the Liver Research Institute, Brown University, United States (2001–2003)
  • Training at the Victorian Infectious Diseases Reference Laboratory (VIDRL), University of Melbourne, Australia (2008–2009)

Career

  • [Major Positions at the Hospital]
  • Director, Digestive Disease Center, Severance Hospital (2024. 4. 22. – present)
  • Director, Division of Gastroenterology, Severance Hospital (2024. 4. 22. – present)
  • Director, Human Resources Management Office, Yonsei University Health System (2021. 6. 7. – 2024. 3. 31.)
  • Director, Liver Center, Severance Hospital (2019. 9. 1. – 2023. 8. 31.)
  • Director, Administrative Office, Yonsei University Health System (2020. 9. 1. – 2021. 6. 6.)
  • Director, Planning and Management Office, Severance Hospital (2016. 9. 1. – 2020. 8. 31.)
  • Director, Care Coordination Center, Severance Hospital (2014. 9. 1. – 2016. 8. 31.)
  • Deputy Director, Care Coordination Center, Severance Hospital (2012. 9. 1. – 2014. 8. 31.)
  • Member, Clinical Division, Future Talent Committee, Yonsei University College of Medicine (2024.8–present)
  • Member, Research Planning Committee, Yonsei University College of Medicine (2024.9.1–2026.3.31)
  • [Research and External Activities]
  • Conducted major multicenter prospective clinical studies (approximately 90 in total, including approximately 60 as principal investigator)
  • International advisory board member for new drug development at a multinational pharmaceutical company
  • Published more than 500 SCI international papers and delivered more than 130 invited lectures overseas
  • Conducted government-funded projects as principal investigator (Ministry of Health and Welfare, Ministry of Education, Science and Technology, and Ministry of Knowledge Economy)
  • Advisory committee member for the Hepatitis Division of the Korea Centers for Disease Control and Prevention, Ministry of Health and Welfare (2013–2017)
  • Research Planning Advisory Committee member, National Evidence-based Healthcare Collaborating Agency (NECA) (2020–2023)
  • Drug Review Advisory Panel member, National Institute of Food and Drug Safety Evaluation (2014–present)
  • Expert member, Central Pharmaceutical Affairs Council, Ministry of Food and Drug Safety (2014–present)
  • Advisory committee member, Korea Institute of Drug Safety and Risk Management (2017–present)
  • Advisory committee member, New Health Technology Assessment Project, National Evidence-based Healthcare Collaborating Agency (NECA) (2013–present)
  • Member, Deliberation Committee on Advanced Regenerative Medicine and Advanced Biopharmaceuticals, Ministry of Health and Welfare (2020–2023)
  • Contributed columns to Health Kyunghyang’s [Liver-Friendly World] (2015–2018)
  • Selected by EBS’s [Myeongui] (2017, 2019) and Monthly Chosun’s [New Myeongui] (2017)
  • Included in Marquis Who’s Who as one of the top 3% of professionals worldwide (2018)
  • Delegate, Korean Medical Association (2024.8–present)
  • Research Planning and Management Committee member, National Evidence-based Healthcare Collaborating Agency (2024.8–present)
  • Selection Committee member for the Kim No-Kyung Award, Korean Association for Clinical Oncology (2024.8–2025.5)
  • Selection and Operations Committee member, Korean Bun-Shee Medical Award (2024.5–)
  • Research Committee member, Korean Medical Association (2024.8–)
  • Operations Committee member, Clinical Trial Safety Support Organization, Korean Academy of Medical Sciences (2024.8–present)

Academic societies

  • [Academic Society Activities]
  • Trustee, Asian Pacific Digestive Disease Foundation (2023. 12–2026.12 / 3 years)
  • Executive Council Member, Asian Pacific Association for the Study of the Liver (APASL) (2023.2–2027.2 / 4 years)
  • Director of Academic Affairs, Korean Academy of Medical Sciences (2024–present)
  • Member, Hepatitis C Clinical Practice Guidelines Revision Committee, Korean Association for the Study of the Liver (2025)
  • Secretary-General, Asian Pacific Association for the Study of the Liver (APASL) (2023)
  • Chair, Scientific Committee, Asian Pacific Association for the Study of the Liver (APASL) (2022)
  • Council member, Korean Association for the Study of the Liver (2023–present)
  • Executive Director of General Affairs, Korean Association for the Study of the Liver (2021–2023)
  • Director of Academic Affairs, Korean Association for the Study of the Liver (2018–2019)
  • Director of Public Relations, Korean Association for the Study of the Liver (2014–2015)
  • Member, Scientific Committee and Planning Committee, Korean Association for the Study of the Liver (2012–2013)
  • Member, Scientific Committee, Korean Association for the Study of the Liver (2010–2011)
  • Member, Publications Committee, Korean Association for the Study of the Liver (2006–2007)
  • Chair, Scientific Committee, Asian Pacific Primary Liver Cancer Expert (APPLE) Conference (2013)
  • Chair, Scientific Committee, Korean Liver Cancer Association (2010–2011)
  • [Journal Editorial Activities]
  • 1. Associate Editor: Journal of Gastroenterology and Hepatology (2010–present), Clinical and Molecular Hepatology (2021–present), Gut and Liver (2017–present), PLoS ONE (2011–2017), Hepatology International (2019–present)
  • 2. Editorial Board Member: Hepatology (2019–2021), Journal of Hepatology (2014–2019), Liver International (2013–present), Scientific Reports (2019–2022)
  • 3. Manuscript reviewer for leading international journals, including NEJM, Lancet, Gastroenterology, Gut, and Hepatology

FAQ

What conditions does Ahn Sang-hun treat?
Ahn Sang-hun (Gastroenterology, Yonsei University Severance Hospital) treats conditions such as Liver diseases (hepatitis, fatty liver, alcoholic liver disease, cirrhosis, acute liver failure).
Where does Ahn Sang-hun see patients?
In Gastroenterology at Yonsei University Severance Hospital. The hospital address is 50-1 Yonsei-ro, Seodaemun-gu, Seoul.
What is Ahn Sang-hun's specialty?
Specialty: Gastroenterology.

Is any information wrong?

Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.